0
Sibutramine - Reductil - Meridia - Sibutral Analysis
€199.00
Tax included
SIBUTRAMINE
Laboratory analysis of drugs to certify the presence of sibutramine and measure the quantity of this active ingredient.
The level of uncertainty of the sibutramine content analysis depends on the declination selected (Standard <20%, Precise <10% or Regulatory <5%).
Follow the instructions to send your drug to our laboratory for analysis.
Results within 15 working days of receipt of sample.
Sibutramine is a drug used to treat obesity by acting as an appetite suppressant. However, it has been withdrawn from the market in many countries due to its cardiovascular side effects.
Sibutramine is the active ingredient in Reductil, Meridia and other specialties previously marketed by various pharmaceutical companies.
Consuming medicines ordered from dubious or illegal sites can be hazardous to your health. It is essential to check that the online pharmacy is serious and has all the necessary authorizations.
If you have any doubts about the origin of the drug, you should carry out an analysis to certify the presence of the active ingredient and check that its dosage in the drug complies with the indicated content.
Analysis
Sibutramine is analyzed by liquid chromatography coupled with UV-Visible spectrophotometric detection (HPLC-UV Visible).
Chemical name
- Chemical name: (±)-1-[1-(4-chlorophenyl)cyclobutyl]-N,N-dimethylmethanamine
- Gross formula: C17H26ClN
- CAS number: 106650-56-0
Therapeutic class
Sibutramine belongs to the class of anorectics (serotonin and norepinephrine reuptake inhibitors, SNRIs).
Description of therapeutic effects
Sibutramine was indicated for :
- Treatment of obesity :
- Promotes the sensation of satiety by inhibiting the reuptake of serotonin and noradrenalin in the brain.
- Slightly increases thermogenesis, contributing to weight loss.
- Long-term weight control :
- Combined with a low-calorie diet and exercise.
⚠️ Warning: Sibutramine has been withdrawn from the market in the European Union, the United States and several other countries due to an increased risk of cardiovascular events (hypertension, infarction, stroke).
Trade names
- Reductil
- Meridia
- Sibutral
⚠️ Drug withdrawn from the market in several countries
Main manufacturers (before withdrawal)
- Abbott Laboratories
- Knoll Pharmaceuticals
- Various generic producers before the ban
⚠️ Beware of counterfeit products: Although withdrawn from the market, sibutramine is still found on some illegal sites. It's essential to check the origin of products and avoid buying online without official authorization.
SIBUTRAMINE
Specific References
Your drug is analyzed by our expert pharmaceutical analysis laboratory.
The drug to be analyzed must be sent in at least 3 copies in its original packaging (box or vial + blister pack) in order to have all the information.
The drug to be analyzed must be sufficiently protected to avoid any deterioration or damage during transport.
The drug to be analyzed must be accompanied by the completed analysis form.
Documents to download:
The use of counterfeit or illegal medicines (without patent authorisation) presents a proven risk to patients' health:
- Absence of the active ingredient
- Under-dosage of the active ingredient
- Over-dosage of the active ingredient
- Toxic synthetic or degradation impurities
- Presence of another active ingredient
- Toxic excipients
- Presence of toxic residual solvents
- ...
The trade in counterfeit medicines is flourishing and growing exponentially with online trading. The authorities believe that more than half of all medicines sold over the Internet are counterfeit or illegal.
Comments (0)
